The MAPK/ERK signaling pathway is an additional crucial target for inhibitors. Inhibitors targeting MAPK/ERK are employed in cancer cells therapies to prevent unrestrained cell expansion and lump growth.Anti-infection inhibitors include a more comprehensive range of agents that target various microorganisms such as viruses, fungi, and parasites. In